The Role of 4G allele in Plasminogen Activator Inhibitor type-1 rs1799889 Gene as Biomarker to Thrombophilic Complication among Type 2 Diabetic Patients

  • Rowida Eljack Ibrahim Department of Hematology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan
  • Khalid Abdelsamea Mohamedahmed Department of Immunology, Faculty of Medical Laboratory Sciences, University of Gezira, Wad Medani, Sudan
Keywords: 4G allele, Plasminogen Activator Inhibitor type-1, rs1799889 Gene, Thrombosis, T2DM

References

Zhao L, Huang P. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk. Int J Clin Exp Med. 2013;6(8):632-40

https://doi.org/10.1186/1741-7015-11-1

PMid:23281898 PMCid:PMC3565939

Ibrahim RE, Ibrahim SEH, Abdalsamea K, Haj-Alzebar AB, Babiker AM, Nour BYM. Evaluation of Common Coagulation Tests in Type2 Diabetic Patients and Association with Diabetic Pre-cardiovascular Complications, Gezira State-Sudan, 2020-2021. Asian Hematology Research Journal. 2021;5(4):1-6.

Almakey EA, Makeen AM, Saeed OK, Mohamedahmed KA. Association between Adiponectin and Insulin Resistance among Sudanese Males with Type 2 Diabetes Mellitus. Chinese J Med Res. 2021;4(2):34-7.

https://doi.org/10.37515/cjmr.091X.4202

Saboor M, Moinuddin M, Ilyas S. Comparison of Platelet CD Markers between Normal Individuals and Untreated Patients with Type 2 Diabetes Mellitus. J Hematol Thromb Dis. 2013;2:123.

https://doi.org/10.4172/2329-8790.1000123

Khalaf FA, Ibrahim HR, Bedair HM, Allam MM, Elshormilisy AA, Ali ST, Gaber WM. Plasminogen activator inhibitor-1 gene polymorphism as a risk factor for vascular complications in type 2 diabetes mellitus. Egypt J Med Hum Genet. 2019;20:18.

https://doi.org/10.1186/s43042-019-0018-1

Aburto-Mejía E, Santiago-Germán D, Martínez-Marino M, Galván-Plata ME, Almeida-Gutiérrez E, López-Alarcón M, et al. Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease. BioMed Res Int. 2017;2017(2):6519704.

https://doi.org/10.1155/2017/6519704

PMid:28271069 PMCid:PMC5320378

Eriksson P, Kallin B, Van 't Hooft FM, Båvenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995;92(6):1851-5.

https://doi.org/10.1073/pnas.92.6.1851

PMid:7892190 PMCid:PMC42380

Chevilley A, Lesept F, Lenoir S, Ali C, Parcq J, Vivien D. Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Front Cell Neurosci. 2015;16(9):415.

https://doi.org/10.3389/fncel.2015.00415

PMid:26528141 PMCid:PMC4607783

Parpugga TK, Tatarunas V, Skipskis V, Kupstyte N, Zaliaduonyte-Peksiene D, Lesauskaite V. The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction. Dis Markers. 2015;2015:260101.

https://doi.org/10.1155/2015/260101

PMid:26273123 PMCid:PMC4529953

Nordt TK, Lohrmann J, Bode C. Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesis. Thromb Res. 2001;103(Suppl 1):S1-5.

https://doi.org/10.1016/S0049-3848(01)00292-4

Published
2022-08-03
How to Cite
Ibrahim, R. E., & Mohamedahmed, K. A. (2022). The Role of 4G allele in Plasminogen Activator Inhibitor type-1 rs1799889 Gene as Biomarker to Thrombophilic Complication among Type 2 Diabetic Patients. Galen Medical Journal, 11, e2247. https://doi.org/10.31661/gmj.v11i.2447